Abbott says third-quarter sales match forecasts
October 22, 2014 at 08:11 AM EDT
Oct 22 (Reuters) - Abbott Laboratories said its third-quarter sales were in line with Wall Street forecasts and that it had slightly changed the terms of a deal to sell generic drugs to Mylan Inc.
